Literature DB >> 8232756

Fusion of myogenic cells to the newly sealed region of damaged myofibres in skeletal muscle regeneration.

T A Robertson1, J M Papadimitriou, M D Grounds.   

Abstract

In regenerating skeletal muscle, sarcoplasmic extensions containing variable numbers of nuclei, widely referred to as 'buds' or 'stumps', are formed at the ends of damaged myofibres. In this paper we investigated whether the nuclei seen in the buds results from fusion of myogenic cells or from migration of myonuclei to the sealed ends of damaged myofibres in murine muscle regenerating after crush injury. The fusion of mononuclear and multinucleate myogenic cells to the buds was demonstrated by transmission electron microscopy. In order to elucidate the frequency and kinetics of cytoplasmic continuity between myotubes and sealed myofibres, we labelled the damaged myofibres with carbocyanine dye DiI (which inserts into the lipid bilayer and travels down continuous membranes) and the samples were then examined by confocal scanning microscopy. This technique showed that there was little fusion between myotubes and myofibres during the first 6 days after crush injury, but significant fusion had occurred by the tenth day especially at the newly sealed region of the damaged myofibre. A scheme for the repair of damaged skeletal muscle is presented.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8232756     DOI: 10.1111/j.1365-2990.1993.tb00451.x

Source DB:  PubMed          Journal:  Neuropathol Appl Neurobiol        ISSN: 0305-1846            Impact factor:   8.090


  17 in total

Review 1.  Myoblast fusion: lessons from flies and mice.

Authors:  Susan M Abmayr; Grace K Pavlath
Journal:  Development       Date:  2012-02       Impact factor: 6.868

2.  The timing between skeletal muscle myoblast replication and fusion into myotubes, and the stability of regenerated dystrophic myofibres: an autoradiographic study in mdx mice.

Authors:  J K McGeachie; M D Grounds
Journal:  J Anat       Date:  1999-02       Impact factor: 2.610

3.  Neutrophils contribute to muscle injury and impair its resolution after lengthening contractions in mice.

Authors:  Francis X Pizza; Jennifer M Peterson; Joel H Baas; Timothy J Koh
Journal:  J Physiol       Date:  2004-11-18       Impact factor: 5.182

4.  Prevention of muscle aging by myofiber-associated satellite cell transplantation.

Authors:  John K Hall; Glen B Banks; Jeffrey S Chamberlain; Bradley B Olwin
Journal:  Sci Transl Med       Date:  2010-11-10       Impact factor: 17.956

Review 5.  Optimizing IGF-I for skeletal muscle therapeutics.

Authors:  Anastassios Philippou; Elisabeth R Barton
Journal:  Growth Horm IGF Res       Date:  2014-06-19       Impact factor: 2.372

6.  Redistribution of cell membrane probes following contraction-induced injury of mouse soleus muscle.

Authors:  G L Warren; D A Lowe; D A Hayes; M A Farmer; R B Armstrong
Journal:  Cell Tissue Res       Date:  1995-11       Impact factor: 5.249

Review 7.  Role of IGF-I signaling in muscle bone interactions.

Authors:  Daniel D Bikle; Candice Tahimic; Wenhan Chang; Yongmei Wang; Anastassios Philippou; Elisabeth R Barton
Journal:  Bone       Date:  2015-11       Impact factor: 4.398

8.  Transfection efficiency along the regenerating soleus muscle of the rat.

Authors:  Magdolna Kósa; Ernő Zádor
Journal:  Mol Biotechnol       Date:  2013-06       Impact factor: 2.695

9.  The effect of delivering the chemokine SDF-1α in a matrix-bound manner on myogenesis.

Authors:  Fabien Dalonneau; Xi Qiu Liu; Rabia Sadir; Jorge Almodovar; Hichem C Mertani; Franz Bruckert; Corinne Albiges-Rizo; Marianne Weidenhaupt; Hugues Lortat-Jacob; Catherine Picart
Journal:  Biomaterials       Date:  2014-03-05       Impact factor: 12.479

10.  Peroxisome proliferator-activated receptor beta activation promotes myonuclear accretion in skeletal muscle of adult and aged mice.

Authors:  C Giordano; A S Rousseau; N Wagner; C Gaudel; J Murdaca; C Jehl-Piétri; B Sibille; P A Grimaldi; P Lopez
Journal:  Pflugers Arch       Date:  2009-05-05       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.